Latest News

Date Title Topic
15 May 2017 FDA Approves Ribociclib-Letrozole Co-Pack for Initial Treatment of HR-positive/HER2-negative Advanced or Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
12 May 2017 FDA Approves Pembrolizumab as First-Line Combination Therapy with Pemetrexed and Carboplatin for Metastatic Non-squamous NSCLC Irrespective of PD-L1 Expression Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
Registration
11 May 2017 NICE Issues Technology Appraisal Guidance for Pegylated Liposomal Irinotecan Gastrointestinal cancers - Anticancer agents & Biologic therapy
10 May 2017 ESMO 2017 Young Oncologists Track – our biggest track to date!
10 May 2017 FDA Grants Accelerated Approval to Avelumab for Urothelial Carcinoma Genitourinary cancers - Cancer Immunology and Immunotherapy
09 May 2017 Patient Guide in Glioma Now Available Also in Spanish
04 May 2017 ELCC 2017 News: Prospective Study Shows Good Concordance of EGFR Mutation Detection Between ctDNA and Tumour Samples Lung and other thoracic tumours
06 May 2017 ELCC 2017 News: Ensartinib Demonstrates CNS Activity in ALK-positive NSCLC Patients Lung and other thoracic tumours - Anticancer agents & Biologic therapy
06 May 2017 ELCC 2017 News: Specific Immune Cell Profiles Tackle on Tumour Immune Escape and Potentially Identify Lung Cancer Patients Responsive to Anti-PD-1 Immunotherapy Cancer Immunology and Immunotherapy
06 May 2017 ELCC 2017 News: Development and Validation of Outcome Prediction Models Aids Effective Use of Radiotherapy in NSCLC Lung and other thoracic tumours
Non-Small-Cell Lung Cancer
05 May 2017 ESMO/ACF Patient Guide in AML Now Available Also in Arabic Language
05 May 2017 ELCC 2017 Press Release: Study Shows White Blood Cell Boosting Drugs Safe During Chemo-Radiotherapy of Lung Cancer Lung and other thoracic tumours
05 May 2017 ELCC 2017 Press Release: Osimertinib Improves Symptoms in Advanced Lung Cancer Patients Lung and other thoracic tumours